Tag: Parkinson’s
Guidance Updated on Treating Motor Symptoms in Early Parkinson Disease
Levodopa preferred as initial dopaminergic therapy for motor symptoms in patients with early Parkinson disease
Parkinson Disease Mortality Up in U.S. From 1999 to 2019
Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications
Osteoarthritis May Be Linked to Increased Risk for Subsequent Parkinson Disease
Highest increased risk for developing Parkinson disease seen among those with knee or hip osteoarthritis
Certain Prostate Drugs Tied to Risk for Parkinson Disease
Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin
Telehealth Use Up Markedly Among Parkinson Patients
Early in the pandemic, majority of Parkinson patients reported experiencing depression symptoms, anxiety, and sleep disturbances
Smartwatch Sensors Could Monitor Parkinson Disease Symptoms
Motor Fluctuations Monitor for Parkinson's Disease system measurements linked to clinical evaluations of tremor severity
Schizophrenia Tied to Increased Risk for Later Parkinson Disease
Authors say risk may be due to alterations in the brain's dopamine system
MIND and Mediterranean Diets Tied to Delayed Parkinson Onset
Strongest association seen in women, with delay in onset of up to 17 years
FUS Subthalamotomy Studied in Asymmetric Parkinson Disease
Motor features improved with focused ultrasound subthalamotomy on the side opposite main motor symptoms
Vitamins E, C Inversely Linked to Risk for Parkinson Disease
Comparing individuals in highest versus lowest tertile of exposure, inverse link seen for both vitamins C and E; no link for beta-carotene, NEAC
